Skip to content
Open access

Long‐term effects of tofogliflozin on renal function in patients with type 2 diabetes: A retrospective multicenter study

Sep 2026 · Journal of Diabetes Investigation · Vol 17, pp. 1917 - 1926 · 0 citations · 23 references
Medicine

Abstract

To investigate the long‐term renal effects of tofogliflozin, with the shortest half‐life among sodium–glucose cotransporter 2 inhibitors, in real‐world clinical practice.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.